These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
586 related items for PubMed ID: 19622129
1. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis. Nair A, Reddy C, Jacob S. Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129 [Abstract] [Full Text] [Related]
2. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Nair A, Vyas H, Shah J, Kumar A. Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811 [Abstract] [Full Text] [Related]
3. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study. Prasad R, Koul V, Anand S, Khar RK. Int J Pharm; 2007 Mar 21; 333(1-2):70-8. PubMed ID: 17116378 [Abstract] [Full Text] [Related]
4. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM, Corish J, Corrigan OI, Fitzpatrick D. Int J Pharm; 2007 Aug 16; 341(1-2):114-24. PubMed ID: 17502130 [Abstract] [Full Text] [Related]
5. Transdermal delivery of zalcitabine: in vitro skin permeation study. Kim DD, Chien YW. AIDS; 1995 Dec 16; 9(12):1331-6. PubMed ID: 8605052 [Abstract] [Full Text] [Related]
8. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Femenía-Font A, Balaguer-Fernández C, Merino V, López-Castellano A. Int J Pharm; 2006 Oct 12; 323(1-2):125-30. PubMed ID: 16809010 [Abstract] [Full Text] [Related]
9. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro. Kumar MG, Lin S. Pharm Dev Technol; 2009 Oct 12; 14(1):106-15. PubMed ID: 18825546 [Abstract] [Full Text] [Related]
10. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. Dubey S, Kalia YN. J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719 [Abstract] [Full Text] [Related]
11. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis. Keerthi H, Panakanti PK, Yamsani MR. PDA J Pharm Sci Technol; 2012 Aug 03; 66(4):318-32. PubMed ID: 22767881 [Abstract] [Full Text] [Related]
12. In vitro and in vivo transdermal studies of atenolol using iontophoresis. Inal O, Kiliçarslan M, Ari N, Baykara T. Acta Pol Pharm; 2008 Aug 03; 65(1):29-36. PubMed ID: 18536170 [Abstract] [Full Text] [Related]
13. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. Cho CW, Shin SC. Int J Pharm; 2004 Dec 09; 287(1-2):67-71. PubMed ID: 15541913 [Abstract] [Full Text] [Related]
15. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl. Silva SM, Hu L, Sousa JJ, Pais AA, Michniak-Kohn BB. Eur J Pharm Biopharm; 2012 Apr 09; 80(3):663-73. PubMed ID: 22137964 [Abstract] [Full Text] [Related]
16. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Narishetty ST, Panchagnula R. Biopharm Drug Dispos; 2004 Jan 09; 25(1):9-20. PubMed ID: 14716748 [Abstract] [Full Text] [Related]